SIC 2835 - In Vitro & In Vivo Diagnostic Substances
Companies
- CLDX - Celldex Therapeutics, Inc.
- IDXX - IDEXX LABORATORIES INC /DE
- LNTH - Lantheus Holdings, Inc.
- MYGN - MYRIAD GENETICS INC
- NEOG - NEOGEN CORP
- NTLA - Intellia Therapeutics, Inc.
- QDEL - QuidelOrtho Corp
- TKNO - Alpha Teknova, Inc.
Related Macro Threads
- Inflation (CPI / PCE / PPI) - 10 indicators, 3 mapped SIC sectors
- US labor market - 12 indicators, 3 mapped SIC sectors
- Growth & output - 13 indicators, 4 mapped SIC sectors
- Money & trade - 2 indicators, 4 mapped SIC sectors
- Government finances - 6 indicators, 3 mapped SIC sectors
- Sector employment - 5 indicators, 5 mapped SIC sectors
- Industrial orders & inventories - 3 indicators, 3 mapped SIC sectors
- Trade & external - 4 indicators, 4 mapped SIC sectors
Macro Context
- INDPRO - Industrial Production: Total Index
- TCU - Capacity Utilization: Total Index
- PPIACO - Producer Price Index by Commodity: All Commodities
- GDPC1 - Real Gross Domestic Product
- DGS10 - Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- FEDFUNDS - Federal Funds Effective Rate
- CES0500000003 - Average Hourly Earnings of All Employees, Total Private
- PAYEMS - All Employees, Total Nonfarm
Sector financials
Peer figures are build-time aggregates of the SEC companyfacts financials already shown on member company pages. As of latest member filing date: 2026-03-02.
| Companies With Data | Companies With Revenue | Aggregate Revenue | Median Revenue | Median Net Margin | Median Operating Margin | Median Revenue Growth | Median Diluted EPS |
|---|---|---|---|---|---|---|---|
| 8 | 8 | 10,404,408,000 | 859,580,500 | -42.02% | -37.78% | -0.53% | -3.85 |
Charts
Member companies by reported revenue
Net margin distribution
Peer Table
| Company | Latest Revenue | Revenue FY | Net Margin | Operating Margin | Revenue Growth | Diluted EPS |
|---|---|---|---|---|---|---|
| IDXX - IDEXX LABORATORIES INC /DE | 4,303,702,000 | 2025 | 24.62% | 31.60% | 10.42% | 13.08 |
| QDEL - QuidelOrtho Corp | 2,730,200,000 | 2025 | -41.45% | -33.67% | -1.89% | -16.69 |
| LNTH - Lantheus Holdings, Inc. | 1,541,609,000 | 2025 | 15.15% | 20.16% | 0.50% | 3.41 |
| NEOG - NEOGEN CORP | 894,661,000 | 2025 | -122.06% | -118.59% | -3.20% | -5.03 |
| MYGN - MYRIAD GENETICS INC | 824,500,000 | 2025 | -44.38% | -46.96% | -1.56% | -3.95 |
| NTLA - Intellia Therapeutics, Inc. | 67,671,000 | 2025 | 16.92% | -3.81 | ||
| TKNO - Alpha Teknova, Inc. | 40,520,000 | 2025 | -42.59% | -41.90% | 7.35% | -0.32 |
| CLDX - Celldex Therapeutics, Inc. | 1,545,000 | 2025 | -77.99% | -3.90 |
Sources
Macro Data
- INDPRO - FRED series INDPRO, source: Board of Governors of the Federal Reserve System
- TCU - FRED series TCU, source: Board of Governors of the Federal Reserve System
- PPIACO - FRED series PPIACO, source: U.S. Bureau of Labor Statistics
- GDPC1 - FRED series GDPC1, source: U.S. Bureau of Economic Analysis
- DGS10 - FRED series DGS10, source: Board of Governors / U.S. Treasury market data
- FEDFUNDS - FRED series FEDFUNDS, source: Board of Governors of the Federal Reserve System
- CES0500000003 - FRED series CES0500000003, source: U.S. Bureau of Labor Statistics
- PAYEMS - FRED series PAYEMS, source: U.S. Bureau of Labor Statistics
SEC Data
- CLDX SEC company page; latest 10-K 0001104659-26-019652; latest 10-Q 0001104659-26-057113
- IDXX SEC company page; latest 10-K 0000874716-26-000038; latest 10-Q 0000874716-26-000076
- LNTH SEC company page; latest 10-K 0001193125-26-073498; latest 10-Q 0001193125-26-210373
- MYGN SEC company page; latest 10-K 0000899923-26-000018; latest 10-Q 0000899923-26-000038
- NEOG SEC company page; latest 10-K 0000950170-25-100064; latest 10-Q 0001193125-26-149599
- NTLA SEC company page; latest 10-K 0001193125-26-076550; latest 10-Q 0001193125-26-215740
- QDEL SEC company page; latest 10-K 0001906324-26-000008; latest 10-Q 0001906324-26-000024
- TKNO SEC company page; latest 10-K 0001850902-26-000002; latest 10-Q 0001850902-26-000008